DCE

ilumed Continues Rapid Expansion to Serve More Physicians, Medicare Beneficiaries in Record-Breaking Year

Retrieved on: 
Wednesday, January 17, 2024
Health, Consumer, Health Technology, Seniors, Health Insurance, Managed Care, General Health, SDOH, Patient, Meal, Medicaid, DCE, Health equity, Medicare, CMS, ACO, Physician, Transport, Recognition, Social, Growth, Nursing

The company grew from four states with more than 24,000 beneficiaries in 2022 to 10 states covering over 56,000 beneficiaries in 2023, with plans to be in 14 states by the end of 2024.

Key Points: 
  • The company grew from four states with more than 24,000 beneficiaries in 2022 to 10 states covering over 56,000 beneficiaries in 2023, with plans to be in 14 states by the end of 2024.
  • Commendation for the company's unwavering dedication to health equity and addressing the Social Determinants of Health (SDOH) needs of its senior patients.
  • “The providers and clinicians partnering with us are those who want to see their patients regularly, reduce readmissions and deliver that routine, accountable care Medicare beneficiaries need.
  • The authors assume responsibility for the accuracy and completeness of the information contained in this document.

SimBioSys receives milestone FDA clearance for its foundational digital precision medicine technology, TumorSight™, enabling expansion to future cutting-edge applications

Retrieved on: 
Thursday, January 4, 2024
Technology, Surgery, Medical Devices, Professional Services, Science, Data Analytics, FDA, Biotechnology, Health, Health Technology, Other Science, Apps, Applications, Research, Software, Data Management, Artificial Intelligence, Oncology, Food, Risk assessment, Neoplasm, Medicine, Woman, Breast cancer, Breast, Surgeon, Cancer, Magnetic resonance imaging, 3D, Artificial intelligence, Patient, DCE, Medical imaging

“This is a landmark moment for the SimBioSys team and our many collaborators.

Key Points: 
  • “This is a landmark moment for the SimBioSys team and our many collaborators.
  • This is the company’s first FDA 510(k)-cleared device from its exciting pipeline of products.
  • “With the significant increase in use of MRIs in early-stage breast cancer, we have a real opportunity to bring imaging to the forefront of precision medicine.
  • This comprehensive approach aims to deliver holistic support for the cancer care journey, epitomizing the promise of precision medicine.

SimBioSys and Mayo Clinic Enter Strategic Collaboration to Advance AI-powered Digital Precision Medicine Platform for Cancer Patients

Retrieved on: 
Tuesday, January 2, 2024
Biotechnology, Technology, Health, Pharmaceutical, Oncology, Research, Software, Artificial Intelligence, Hospitals, Surgery, Science, Melanoma, Surgical oncology, Quality of life, National Cancer Institute, Neoplasm, Medicine, Breast cancer, FDA, NCI-designated Cancer Center, Education, Heart, Cancer, AI, 3D, Mayo Clinic, Artificial intelligence, Genomics, Patient, Translational research, NCI, DCE, Skin, Medical imaging

SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and biophysical modeling to redefine precision medicine for cancer, announced today it has entered into a strategic collaboration agreement with Mayo Clinic for the development of novel digital precision medicine solutions for breast cancer patients.

Key Points: 
  • SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and biophysical modeling to redefine precision medicine for cancer, announced today it has entered into a strategic collaboration agreement with Mayo Clinic for the development of novel digital precision medicine solutions for breast cancer patients.
  • As part of the collaboration, SimBioSys has had access to and has been analyzing data from patients who participated in the Mayo Clinic-led BEAUTY clinical trial ( NCT02022202 ).
  • "SimBioSys complements current precision medicine techniques while only relying on readily available and previously acquired datasets such as imaging.
  • Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

SimBioSys Presents New Data for Breast Cancer Personalized Medicine Platforms at the 46th Annual San Antonio Breast Cancer Symposium

Retrieved on: 
Tuesday, December 12, 2023
Biotechnology, Health, Biometrics, Surgery, Oncology, Other Science, Research, General Health, Hospitals, Genetics, Health Technology, Health Insurance, Science, Clinical Trials, Forecast, Neoplasm, Neoadjuvant therapy, Breast cancer, Surgeon, Perfusion, Patient, Tumor microenvironment, NAT, Artificial intelligence, BCS, Gene expression, Radiomics, Mastectomy, HER2, Cancer, PET, SOC, DCE, Medical imaging, Medical device, Dentistry, Health insurance, Simbiosys

SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and data science to redefine precision medicine for cancer with software tools, recently presented new data from its TumorSight and PhenoScope platforms at the 46th Annual San Antonio Breast Cancer Symposium (SABCS), held from December 5-9, 2023.

Key Points: 
  • SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and data science to redefine precision medicine for cancer with software tools, recently presented new data from its TumorSight and PhenoScope platforms at the 46th Annual San Antonio Breast Cancer Symposium (SABCS), held from December 5-9, 2023.
  • The results included collaborations with top cancer research institutions, multi-institutional analysis, enhanced visualization, and volumetric prediction capabilities to aid surgical planning.
  • (PO2-02-11) Radiomics and an Erosion Model to Predict Post-Neoadjuvant Therapy Tumor Characteristics for Personalized Breast Cancer Treatment.
  • Research Summary: Early breast cancer Patient Opinion Leaders (POLs) and surgeons were surveyed to assess TumorSight’s potential impact on shared decision making for breast cancer surgical options.

T1 E1 Network Test Solution Capabilities

Retrieved on: 
Thursday, November 2, 2023
CAS, DCE, Linux, PC, WCS, DTE, GSM, Analyser, Command-line interface, SSH, FXS, GL, Telephone, Python, Unix, WLC, PPP, Maintenance, USB, Frame Relay, SS7, Microsoft Windows, Telecom, PowerShell, ISDN, SS1, FXO, Probe, Collection, HDLC, Automation, Data analysis, Communication, Console, Emulation, Mobile phone, Video game, Internet service provider, Computer data storage, Computer network

“GL's tProbe™ is a test and measurement device for T1 E1 networks.

Key Points: 
  • “GL's tProbe™ is a test and measurement device for T1 E1 networks.
  • GL's Windows Client/Server (WCS) software allows T1 E1 analysis and emulation cards with remote operation, automation, and multi-site connectivity capabilities.
  • It sends commands to T1 E1 WCS servers and shows the responses in Console, PowerShell, or Terminal Windows.
  • Available with Dual T1 or E1, FXO, FXS, DTE and DCE interfaces
    Bit Error Rate Testing over all timeslots.

ilumed Achieves 100% Quality Score and $30 Million in Medical Cost Savings in 2022 ACO REACH Results

Retrieved on: 
Thursday, November 2, 2023
White House, Federal Government, Public Policy, Government, Health, Practice Management, Health Insurance, General Health, DCE, Accountable care organization, Direct, Acos, Medicare, Physician, PCP, Organization, REACH, Transport, Community health, Hospital, Centers for Medicare & Medicaid Services, Patient, Empathy, CMS, ACO, Nursing, Health care, Access

In addition to high quality scores, ilumed achieved $30,980,318 of gross savings for Medicare and $23,609,820 of net savings, which will be shared with qualifying physician partners, invested in infrastructure and resources to further improve quality of care, and used to address social determinants of health -- including providing healthy food to those who are food insecure, providing transportation to physician and pharmacy appointments, and eliminating PCP copays and deductibles.

Key Points: 
  • Medicare data shows that ilumed earned a quality score of 100% on all five quality metrics.
  • These performance measures range from risk-standardized all-condition readmission to timely follow-up after acute exacerbations of chronic conditions, among others.
  • Dr. Eric Weiner, an ilumed primary care physician, has found the relationship with the DCE/ACO REACH model especially beneficial.
  • ACO REACH creates incentives for ACOs to invest in transforming care by allowing them to share in savings they generate after meeting defined quality and cost goals.

Harvard Division of Continuing Education Launches New Professional Development Programs

Retrieved on: 
Tuesday, October 3, 2023
Linda, PACE Institute of Leadership and Management, Harvard University, DCE, Communication, Marketing, Cross, Organization, Continuing education, Cornell University School of Hotel Administration, Harvard Division of Continuing Education, Harvard Business School, Professional development, Management, Innovation

CAMBRIDGE, Mass., Oct. 3, 2023 /PRNewswire/ -- The Harvard Division of Continuing Education (DCE) introduced three new programs this fall offered through its Professional Development unit.

Key Points: 
  • CAMBRIDGE, Mass., Oct. 3, 2023 /PRNewswire/ -- The Harvard Division of Continuing Education (DCE) introduced three new programs this fall offered through its Professional Development unit.
  • The three new programs are:
    With these new programs, Harvard DCE will offer 53 unique programs in 2024 to help professionals build essential skills.
  • "We surveyed business leaders and tapped into market trends to determine which programs to add to our portfolio," said Linda Cross, Senior Director of Professional Development, Harvard DCE.
  • "Robust discussions are a critical part of developing professional skills, which is why our professional development programs are taught live and not recorded," added Cross.

PortPro’s Toni Ann Careccio is Honored with 2023 Women in Supply Chain Award

Retrieved on: 
Wednesday, September 20, 2023
Demand, DCE, Supply & Demand Chain Executive, Woman, Research, Strategic planning, Food, Motivation, Growth, LOS, Management, Supply

JERSEY CITY, N.J. and LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- PortPro , the premier drayage software provider for drayage carriers, announced that Toni Ann Careccio, Chief Customer Officer and Board Member, has been recognized as a top 2023 Women In Supply Chain.

Key Points: 
  • JERSEY CITY, N.J. and LOS ANGELES, Sept. 20, 2023 (GLOBE NEWSWIRE) -- PortPro , the premier drayage software provider for drayage carriers, announced that Toni Ann Careccio, Chief Customer Officer and Board Member, has been recognized as a top 2023 Women In Supply Chain.
  • The annual recognition, led by Supply & Demand Chain Executive (S&DCE) and Food Logistics, honors female supply chain leaders and executives whose accomplishments, mentorship and examples set a foundation for women in all levels of a company’s supply chain network.
  • As more women enter supply chain and logistics industries, their diverse experiences, perspectives, and skill sets will foster more innovation, collaboration, and efficiency.
  • Recipients will be honored at this year’s Women in Supply Chain Forum, set to take place November 14-15, 2023 in Atlanta.

Taking Computer Vision in Healthcare to the Next Level with Dynamsoft Vision Framework

Retrieved on: 
Monday, July 17, 2023
DLR, Database, Localization, Workflow, DCE, Health care, API, DCP, ID, MRZ, Government, Vision, Organization, OCR, Acquisition, DDN, DBR, IDS, Visage SDK, SDK, Security printing, Computer data storage, Medical imaging, Fine chemical, Dynamsoft

VANCOUVER, British Columbia, July 17, 2023 /PRNewswire-PRWeb/ -- Dynamsoft™ released Dynamsoft Barcode Reader SDK C++ Edition v10.0.0. The updated SDK has been refactored into a brand-new experience for Dynamsoft's computer vision SDK product line, which is designed to adapt to a variety of different image-processing scenarios to derive and extract useful information from images. Dynamsoft Vision framework allows developers to easily apply computer vision algorithms to perform various tasks on input images and videos and extract useful information for further processing. The Vision framework includes the following image-processing products:

Key Points: 
  • VANCOUVER, British Columbia, July 17, 2023 /PRNewswire-PRWeb/ -- Dynamsoft™ released Dynamsoft Barcode Reader SDK C++ Edition v10.0.0.
  • Dynamsoft Vision framework allows developers to easily apply computer vision algorithms to perform various tasks on input images and videos and extract useful information for further processing.
  • The Vision framework includes the following image-processing products:
    Dynamsoft Barcode Reader (DBR) - Robust high-speed 1D & 2D barcode scanner.
  • This update consolidates all of Dynamsoft's image processing capabilities into a single framework and represents a significant step forward for Dynamsoft and its customers.

Harvard Extension School Reduces Degree Residency Requirement, Expanding Access for Global Adult Learners

Retrieved on: 
Wednesday, June 21, 2023
Harvard Extension School, Education, Harvard University, DCE, Harvard Division of Continuing Education, Master of Arts in Liberal Studies, HES, Continuing education, Student, ALM, Geography, Tutoring

CAMBRIDGE, Mass., June 21, 2023 /PRNewswire/ -- Harvard University's Division of Continuing Education (DCE) announced a significant modification to the degree residency requirement at the Harvard Extension School (HES) to provide greater access to adult learners worldwide.

Key Points: 
  • CAMBRIDGE, Mass., June 21, 2023 /PRNewswire/ -- Harvard University's Division of Continuing Education (DCE) announced a significant modification to the degree residency requirement at the Harvard Extension School (HES) to provide greater access to adult learners worldwide.
  • Starting in the upcoming academic year, the Harvard Extension School will offer the majority of courses for the Master of Liberal Arts (ALM) graduate degrees online with a low residency requirement.
  • This decision reduces the barrier of geography for those outside of the greater New England area.
  • Harvard Extension School's revision of the degree residency requirement represents a progressive approach to education, ensuring that adult learners worldwide can pursue advanced degrees on their terms.